EUVIMEDEUVIMED entdecken
Crossref

Can the contralateral systematic prostate biopsy be omitted in men with unilateral index lesion on MRI? A single-center retrospective study

Yongsheng Nian, Qiuya Xu, Yongbing Cheng, Danyan Li, Li Zhu, Haifeng Huang, Yao Fu, Shan Peng, Hongqian Guo, Xuefeng Qiu

World Journal of Urology · 2025

DOI: 10.1007/s00345-025-05759-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, 2025. Verfasst von Yongsheng Nian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Affiliated Hospital of Medical School, Institute of Urology, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, 210009,…. Hauptthemen laut MEDLINE: Unnecessary Procedures, Image-Guided Biopsy, Prostate, Prostatic Neoplasms. Die Arbeit nennt 19 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Nanjing Drum Tower Hospital Clinical Research Special Funding Program, Nanjing Drum Tower Hospital Clinical Research Special Fund Cultivation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The objective of this study was to evaluate the diagnostic efficacy of combining prostate targeted biopsy (TB) with ipsilateral systematic biopsy (iSB) for men with unilateral index lesion on magnetic resonance imaging (MRI). METHODS: This single-center, retrospective study included 654 patients with unilateral index lesion (PI-RADS ≥ 3) on MRI who underwent prostate target biopsy combined with 12-core systematic biopsy (SB) between January 2022 to February 2023. The index lesion was defined as the lesion with the highest PI-RADS score or, in cases of multiple lesions with the same highest score, the one with the largest diameter. Ipsilateral systematic biopsy (iSB) was defined as the hemi-lateral systematic biopsy on the same side as the index lesion on MRI, while contralateral systematic biopsy (cSB) was defined as the hemi-lateral systematic biopsy on the opposite side. Kappa consistency analysis was conducted to compare the csPCa detection rates between TB combined with SB (TB + SB) and TB combined with iSB (TB + iSB). The McNemar test was used to compare the csPCa detection rates between TB + iSB and TB + cSB. RESULTS: The csPCa detection rate was higher for TB + iSB than for TB + cSB (44.87% vs. 42.73%, P 20 ng/ml (66.67% vs. 68.9%, P < 0.01). CONCLUSION: TB + iSB, which omits half of the SB cores, demonstrates extremely high consistency with TB + SB in detecting csPCa in men with unilateral index lesion on MRI, and has a higher csPCa detection rate compared to TB + cSB, indicating its potential to replace TB + SB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Unnecessary ProceduresImage-Guided BiopsyProstateProstatic NeoplasmsRetrospective StudiesDiffusion Magnetic Resonance ImagingHumansMaleMiddle AgedAged

Stichwörter der Autor:innen

Contralateral systematic biopsyIpsilateral systematic biopsyProstate cancerTarget biopsyUnilateral systematic biopsy

Autor:innen und Institutionen

  • Department of Urology, Affiliated Hospital of Medical School, Institute of Urology, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, 210009, China.
  • Department of Urology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210009, China.
  • Department of Radiology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, 210009, China.
  • Department of Pathology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, 210009, China.
  • Department of Urology, Affiliated Hospital of Medical School, Institute of Urology, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, 210009, China. dr.ghq@nju.edu.cn.
  • Department of Urology, Affiliated Hospital of Medical School, Institute of Urology, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, 210009, China. Xuefeng_qiu@nju.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Nanjing Drum Tower Hospital Clinical Research Special Funding Program
  • Nanjing Drum Tower Hospital Clinical Research Special Fund Cultivation Project

Zitieren

APA

Nian, Y., Xu, Q., Cheng, Y., Li, D., Zhu, L., Huang, H., Fu, Y., Peng, S., Guo, H., & Qiu, X. (2025). Can the contralateral systematic prostate biopsy be omitted in men with unilateral index lesion on MRI? A single-center retrospective study. World Journal of Urology. https://doi.org/10.1007/s00345-025-05759-2

Vancouver

Nian Y, Xu Q, Cheng Y, Li D, Zhu L, Huang H, et al. Can the contralateral systematic prostate biopsy be omitted in men with unilateral index lesion on MRI? A single-center retrospective study. World Journal of Urology. 2025. doi:10.1007/s00345-025-05759-2

BibTeX
@article{Nian2025,
  author = {Nian, Yongsheng and Xu, Qiuya and Cheng, Yongbing and Li, Danyan and Zhu, Li and Huang, Haifeng and Fu, Yao and Peng, Shan and Guo, Hongqian and Qiu, Xuefeng},
  title = {Can the contralateral systematic prostate biopsy be omitted in men with unilateral index lesion on MRI? A single-center retrospective study},
  journal = {World Journal of Urology},
  year = {2025},
  doi = {10.1007/s00345-025-05759-2}
}
Kostenlos starten →